Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	53	5	12	5	4	31
Market Cap Growth	911.44%	-54.11%	152.98%	5.76%	-85.77%	145.72%
Enterprise Value	50	6	63	60	58	87
Last Close Price	1.90	1.23	2.70	1.08	1.04	7.47
PE Ratio	2.18	0.22	1.90	2.40	-	-
PS Ratio	1.45	0.14	0.25	0.12	0.14	0.94
PB Ratio	2.28	0.24	-5.35	-0.52	-0.27	7.57
P/TBV Ratio	2.28	0.24	-	-	-	-
P/FCF Ratio	11.64	1.00	3.15	1.41	-	-
P/OCF Ratio	10.79	0.93	2.56	1.24	-	-
EV/Sales Ratio	1.38	0.16	1.35	1.49	1.82	2.62
EV/EBITDA Ratio	9.77	1.21	7.55	11.97	-	-
EV/EBIT Ratio	12.26	1.31	7.83	15.07	-	-
EV/FCF Ratio	11.05	1.15	16.84	18.00	-	-
Debt / Equity Ratio	0.05	0.05	-2.64	-1.24	-0.97	2.60
Debt / EBITDA Ratio	0.20	0.20	0.64	1.93	-	34.59
Debt / FCF Ratio	0.22	0.22	1.55	3.37	-	-
Net Debt / Equity Ratio	-0.06	-0.06	-1.98	-0.85	-0.68	1.96
Net Debt / EBITDA Ratio	-0.25	-0.25	0.52	1.54	-8.80	-20.65
Net Debt / FCF Ratio	-0.24	-0.24	1.17	2.32	-1.40	-0.89
Asset Turnover	1.59	1.59	3.36	2.75	1.17	0.79
Inventory Turnover	12.56	12.56	13.95	12.22	13.28	9.95
Quick Ratio	1.60	1.60	0.94	0.75	0.69	0.47
Current Ratio	1.94	1.94	1.11	0.91	0.85	0.78
Return on Equity (ROE)	248.03%	248.03%	-	-	-	-65.25%
Return on Assets (ROA)	12.30%	12.30%	36.32%	17.03%	-8.82%	-8.57%
Return on Invested Capital (ROIC)	44.34%	41.21%	1864.97%	-	-111.35%	-36.49%
Return on Capital Employed (ROCE)	16.60%	16.60%	194.10%	235.90%	-226.40%	-25.30%
Earnings Yield	44.93%	451.08%	56.45%	41.64%	-494.86%	-47.92%
FCF Yield	8.59%	100.50%	31.75%	70.72%	-180.61%	-29.10%
Buyback Yield / Dilution	-76.02%	-76.02%	-260.54%	-2.97%	-2.49%	-2.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.